https://www.selleckchem.com/pr....oducts/abbv-2222.htm
Since August 2016, after the Ebola outbreak, the Guinean National Tuberculosis Programme and Damien Foundation implemented the shorter treatment regimen (STR) for multidrug-resistant tuberculosis (MDR-T in the three MDR-TB sites of Conakry. Previously, the longer regimen was used to treat MDR-TB. In a post-Ebola context, with a weakened health system, we describe the MDR-TB treatment uptake, patients characteristics, treatment outcomes and estimate the effect of using the longer versus STR on having a programmatically adverse outcom
Like
Comment
Share
